Role of chest ultrasound in evaluation of pleuropulmonary diseases in critically ill patients

Authors

Dena M. Serag, Menoufia University
Eslam H.A. A. Hemeda, Ministry of HealthFollow
Mohamed S.E. Elzawawi, Menoufia University

Subject Area

Radiology and Imaging Sciences

Article Type

Original Study

Abstract

Objective To assess the diagnostic performance of lung ultrasound (LUS) compared with chest radiograph (CXR) in critically ill patients with pleuropulmonary diseases. Background LUS is an interesting and effective diagnostic tool for major pleuropulmonary diseases that can obviate the need of unnecessary radiations. Patients and methods This prospective study took place in the duration from October 2020 to October 2021 on 50 patients admitted to ICU at Menoufia University Hospital, comprising 27 (54%) males and 23 (46%) female. All patients were subjected to LUS, CXR, and computed tomography as the gold standard test for diagnosis. Results The overall accuracy of LUS was higher and statistically significant compared with CXR in the diagnosis of pleural effusion, pneumonia, pulmonary edema, and pneumothorax (94.29, 94.83, 95, and 98.87%, respectively). Conclusion LUS is a precise, safe bedside diagnostic tool for pleuropulmonary diseases that offers a comparable accuracy to computed tomography in ICU patients.

Recommended Citation

Serag, Dena M.; Hemeda, Eslam H.A. A.; and Elzawawi, Mohamed S.E. (2023) "Role of chest ultrasound in evaluation of pleuropulmonary diseases in critically ill patients," Menoufia Medical Journal: Vol. 35: Iss. 4, Article 45.
DOI: https://doi.org/10.4103/mmj.mmj_264_22